$ARR

Armour Residential REIT, Inc.

No enriched coverage for $ARR in the last 7 days.

No SEC Form 4 filings for $ARR in the last 30 days.

Med

ARMOUR (NYSE: ARR) investors OK new stock plan, annual pay vote

ARMOUR Residential REIT, Inc. (ARR) stockholders approved a new Fourth Amended and Restated 2009 Stock Incentive Plan, authorizing an additional 1,000,000 common shares. At their April 30, 2026 annual meeting, shareholders also elected all eight director nominees, ratified Deloitte & Touche LLP as the 2026 auditor, approved 2025 executive compensation, and supported annual advisory votes on executive pay. The company confirmed its intention to hold "say-on-pay" votes annually, aligning with shareholder preference.

ARMOUR Residential REIT Shareholders Approve Expanded Incentive Plan

ARMOUR Residential REIT shareholders approved an expanded stock incentive plan, re-elected directors, and ratified their independent auditor at their annual meeting on April 30, 2026. This expansion adds 1,000,000 shares for equity and cash awards, updating plan terms to include lower per-person limits, a 10-year term, and a clawback provision. The approvals signify strong investor support for the company's leadership, compensation strategy, and governance framework.

Assessing ARMOUR Residential REIT’s Valuation As Q1 Loss Counters Dividend Coverage And Capital Raises

ARMOUR Residential REIT (ARR) reported a Q1 2026 net loss due to mark-to-market pressure, though non-GAAP distributable earnings covered its monthly dividend. Despite a 31% one-year total return and recent share price gains, analysts estimate fair value at $17, slightly below its current trading price of $17.62, suggesting the stock is modestly overvalued based on this narrative, while its P/E ratio suggests a potential value cushion.